1 / 21

Ensuring Access to Safe, Affordable and Quality Essential Medicines

3 rd MeTA Philippines Forum. Ensuring Access to Safe, Affordable and Quality Essential Medicines. Dr. Edelina P. Dela Paz, MD Health Action Information Network January 27, 2009. Maximum Drug Retail Price (MDRP) and Government Mediated Access Price (GMAP).

maya
Télécharger la présentation

Ensuring Access to Safe, Affordable and Quality Essential Medicines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 3rd MeTA Philippines Forum Ensuring Access to Safe, Affordable and Quality Essential Medicines Dr. Edelina P. Dela Paz, MD Health Action Information Network January 27, 2009

  2. Maximum Drug Retail Price (MDRP) and Government Mediated Access Price (GMAP) Implemented starting August 15, 2009 21 medicines (5 under MDRP and 16 under GMAP) • 5 cardiovascular drugs • 1 anti-diabetic • 5 antibiotics • 10 cancer chemotherapy drugs

  3. Maximum Drug Retail Price (MDRP) and Government Mediated Access Price (GMAP) Prices reduced by ~50% based on price of originator or leading brand

  4. Impact on access to medicines for the poor? 45% of Filipinos live on less than 2$ a day 22.6% of Filipinos live on less than 1$ a day Human Development Report 2009, UNDP

  5. Survey on Medicine Prices and Availability HAIN survey on prices and availability of selected medicines in 1st quarter 2009 Prices and availability across 27 private pharmacies and 21 public outlets Affordability computed based on median prices and wages for lowest paid government worker at the time of survey

  6. Survey on Medicine Prices and Availability Philippine prices were compared to international reference prices and described as median price ratios (number of times Philippine price is more expensive than int’l reference price)

  7. Prices in public outlets are lower than in private outlets, but… The prices of surveyed generic medicines in private outlets is about 3 times more expensive than those in public outlets.

  8. …availability in public outlets is poorer than in private outlets. *availability of 30 selected essential medicines

  9. Much cheaper generic equivalents, compared to the MDRP, have already been available. *in surveyed private outlets

  10. “Cheaper” may not always mean “affordable.” Affordability of 30-Day Treatment Course of Amlodipine 5 mg tablet *Based on salary of lowest-paid government worker at the time of survey

  11. Much cheaper generic equivalents, compared to the GMAP, have already been available. *in surveyed private outlets

  12. “Cheaper” may not always mean “affordable.” Affordability of 7-Day Treatment Course of Ciprofloxacin 500 mg tablet *Based on salary of lowest-paid government worker at the time of survey

  13. “Cheaper” may not always mean “affordable.” 45% of Filipinos live on less than 2$ a day 22.6% of Filipinos live on less than 1$ a day Human Development Report 2009, UNDP

  14. “Cheaper” may not always mean “affordable.” Medicines are not the only source of expense for a patient. - laboratory exams/procedures - if hospitalized, room and board - professional fees Human Development Report 2009, UNDP

  15. The imposition of price regulatory control for medicines may be a positive step for patients at this time, but a combination of more comprehensive policies is needed for medicines to be truly affordable to the poor.

  16. Clearly the MDRP and the GMAP are not the prime solution to making essential medicines available and affordable to our people, especially the poor. • The duration for patent on medicines must be shortened so as not to allow monopoly or control of foreign transnational companies in the Philippines

  17. Drug Price Regulatory Board with a democratic representation of consumers and other stakeholders can be set up temporarily for 3-5 years until processes and mechanisms for price regulation will now be in place. Price regulation can not be left only on the authority of the Secretary of Health and the President of the Philippines. Stakeholder consultations must be conducted.

  18. Implementation of National Drug Policies and programs • Generics Law • ensuring the quality of generic medicines • improving the availability of generic medicines in public and private outlets • more intensive promotion of low priced generic medicines to the public

  19. Develop a self reliant national drug industry that is responsive to the health needs of our people, especially the poor • Develop technology that will extract and refine raw materials and chemicals for medicine production locally • Improve the potentials of herbal medicine and natural components that are found locally in the Philippines

  20. Access to essential medicines is part of the people’s right to health. • Currently, this right is indeed being violated and the people must demand that it be freely given.

  21. The need of Filipinos for safe, efficacious, affordable and quality essential medicines can only be met when a strong national health care system is in place and under a government whose policies consider the best interest of its people.

More Related